Jeff Wagener, M.D.
Affiliations: | Pediatrics | University of Colorado, Boulder, Boulder, CO, United States |
Google:
"Jeff Wagener"Parents
Sign in to add mentorLynn Taussig | fellowship/program director | 1978-1981 | University of Arizona |
Children
Sign in to add traineeTerri A. Laguna | fellowship/program director | CU Boulder | |
Deborah R. Liptzin | fellowship/program director | 2012-2015 |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wagener JS, Williams MJ, Millar SJ, et al. (2018) Pulmonary exacerbations and acute declines in lung function in patients with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society |
McKone E, Sawicki G, Millar S, et al. (2016) ePS03.4 Improved rate of decline in percent predicted FEV 1 (ppFEV 1 ) is not associated with acute improvement in ppFEV 1 in patients with cystic fibrosis (CF) treated with ivacaftor Journal of Cystic Fibrosis. 15: S42 |
Rubin-Cahill J, Thayer S, Watkins A, et al. (2015) 191 Lung function and health care resource utilization in patients with cystic fibrosis Journal of Cystic Fibrosis. 14: S107 |
Rubin-Cahill J, Thayer S, Watkins A, et al. (2015) 190 Frequency and costs of pulmonary exacerbations and association with % predicted FEV 1 in patients with cystic fibrosis Journal of Cystic Fibrosis. 14: S106 |
Sawicki G, McKone E, Pasta D, et al. (2014) WS3.1 The effect of ivacaftor on the rate of lung function decline in CF patients with a G551D-CFTR mutation Journal of Cystic Fibrosis. 13: S6 |
Sagel SD, Gibson RL, Emerson J, et al. (2009) Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. The Journal of Pediatrics. 154: 183-8 |